Table 2

Comparison of endpoints at six weeks expressed as changes from baseline.

Treatment

Placebo

P value

Total Cholesterol (mmol/L)

-0.3 ± 0.1 ***

-0.1 ± 0.08

0.184

LDL cholesterol (mmol/L)**

-0.3 ± 0.1 ***

-0.04 ± 0.08

0.026

HDL cholesterol (mmol/L)

-0.02 ± 0.02

-0.009 ± 0.02

0.842

Triglyceride (mmol/L)*

0.09 ± 0.1

-0.2 ± 0.1***

0.030

Cholesterol/HDL ratio

-0.2 ± 0.1

-0.1 ± 0.1

0.947

C-Reactive protein (mg/dL)

-0.03 ± 0.06

0.01 ± 0.04

0.546

Homocysteine (μM/L)

0.4 ± 0.4

0.2 ± 0.2

0.528

Insulin (pmol/L)

6.9 ± 4.9

4.2 ± 10.4

0.804

Glucose (mmol/L)

0.2 ± 0.09

0.03 ± 0.09

0.259

Weight (kg)

-0.7 ± 0.3

1.4 ± 1.3

0.117

Blood pressure (systolic/diastolic, mmHg, value at end point)

119/69 ± 1.9/1.3

119/69 ± 2.0/1.7

0.832/0.856

Total Energy Intake per day (kJ)

-519 ± 330

-343 ± 360

0.724

Carbohydrate intake (% of total)

0.4 ± 2.0

1.8 ± 1.3

0.535

Protein Intake (% of total)

0.9 ± 0.6

-0.9 ± 1.1

0.041

Fat Intake (% of total)

-0.7 ± 1.8

-1.2 ± 1.1

0.784

Dietary Fiber Intake (grams)

-0.3 ± 1.1

-1.4 ± 1.6

0.454

Data are means ± SEM.

***Statistically different from baseline, within group comparison p < 0.05

Queenan et al. Nutrition Journal 2007 6:6   doi:10.1186/1475-2891-6-6